CSFB Raises its Price Target on VRTX after Hepatitis C Results

May 10, 2005 10:39 AM EDT Send to a Friend
UPDATE: CSFB raised its price target on Vertex Pharma (Nasdaq: VRTX) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login